ResourcesVendorsArtificial IntelligenceSystemsicometrixKolonel Begaultlaan 1b, Leuven, BelgiumeMail:Website:https://www.icometrix.comLatest from icometrixMRIIcometrix gains EU approval for ARIA monitoring AI softwareBy AuntMinnieEurope.com staff writersIcometrix has gained approval to market its icobrain aria software in the European Union (EU), along with Israel, Japan, Switzerland, and the U.K.September 4, 2024ConferenceVideo from ECR 2019: Hugh Harvey on validation of AIClinical validation of artificial intelligence (AI) is still a long way off, admits Dr. Hugh Harvey, who moderated the Artificial Intelligence Exhibition (AIX) at ECR 2019 with Dr. Wim Van Hecke, CEO of icometrix in Leuven, Belgium. In this interview, Harvey, clinical director at Kheiron Medical, reflects on the future development of AI and the unresolved issues that need to be addressed.March 3, 2019Clinical NewsMRI 2028: What to expect in the next decade of MRI?By Steve HollowayThe 50th anniversary of MRI for clinical use is on the horizon. MRI has remained at the pinnacle of diagnostic imaging, influencing many advances in radiology. As we enter an increasingly digital era, what role will MRI play? Market analyst Stephen Holloway explores some recent developments and speculates about the future.March 8, 2018ConferenceNecessity of gadolinium contrast comes under scrutinyBy Katrina MeggetGadolinium-enhanced MRI scans have been the gold standard in suspected cases of vestibular schwannoma and multiple sclerosis (MS), but given the growing evidence of deposits left in the brain, debate has ensued about how to image wisely. Is it always necessary to use gadolinium contrast agents? Regarding vestibular schwannoma and MS, today's Pros and Cons Session will explore this question.March 1, 2018
